Xerostomia (Dry Mouth) Therapeutics Market Exhibiting At USD 796.1 Million By 2025 : Grand View Research Inc.
San Francisco, 11 September 2019: The Report Xerostomia (Dry Mouth) Therapeutics Market Analysis By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region, And Segment Forecasts, 2018 – 2025 The global xerostomia therapeutics market is expected to reach USD 796.1 million by 2025, according to a new report by Grand View Research, Inc. Increase in favorable reimbursement policies for xerostomia products and growing awareness about associated diseases are the major factors contributing toward market growth. In addition, increasing prevalence of xerostomia and associated diseases such as Sjogren’s syndrome, diabetes, hypertension, and Parkinson’s disease has a positive impact on the overall market. According to Colgate-Palmolive Company, 25 million people in the U.S. experience dry mouth. According to Sjogren Syndrome Foundation of America, around 4 million Americans are suffering from Sjogren’s syndrome, an autoimmune disorder.